These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 35104835)

  • 1. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
    Suzuki R; Yamasoba D; Kimura I; Wang L; Kishimoto M; Ito J; Morioka Y; Nao N; Nasser H; Uriu K; Kosugi Y; Tsuda M; Orba Y; Sasaki M; Shimizu R; Kawabata R; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Sawa H; Ikeda T; Irie T; Matsuno K; Tanaka S; Fukuhara T; Sato K
    Nature; 2022 Mar; 603(7902):700-705. PubMed ID: 35104835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
    Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
    Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
    Saito A; Irie T; Suzuki R; Maemura T; Nasser H; Uriu K; Kosugi Y; Shirakawa K; Sadamasu K; Kimura I; Ito J; Wu J; Iwatsuki-Horimoto K; Ito M; Yamayoshi S; Loeber S; Tsuda M; Wang L; Ozono S; Butlertanaka EP; Tanaka YL; Shimizu R; Shimizu K; Yoshimatsu K; Kawabata R; Sakaguchi T; Tokunaga K; Yoshida I; Asakura H; Nagashima M; Kazuma Y; Nomura R; Horisawa Y; Yoshimura K; Takaori-Kondo A; Imai M; ; Tanaka S; Nakagawa S; Ikeda T; Fukuhara T; Kawaoka Y; Sato K
    Nature; 2022 Feb; 602(7896):300-306. PubMed ID: 34823256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
    Martins M; Nooruzzaman M; Cunningham JL; Ye C; Caserta LC; Jackson N; Martinez-Sobrido L; Fang Y; Diel DG
    J Virol; 2024 Mar; 98(3):e0190223. PubMed ID: 38421180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation.
    Chen DY; Chin CV; Kenney D; Tavares AH; Khan N; Conway HL; Liu G; Choudhary MC; Gertje HP; O'Connell AK; Adams S; Kotton DN; Herrmann A; Ensser A; Connor JH; Bosmann M; Li JZ; Gack MU; Baker SC; Kirchdoerfer RN; Kataria Y; Crossland NA; Douam F; Saeed M
    Nature; 2023 Mar; 615(7950):143-150. PubMed ID: 36630998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
    Yamasoba D; Kimura I; Nasser H; Morioka Y; Nao N; Ito J; Uriu K; Tsuda M; Zahradnik J; Shirakawa K; Suzuki R; Kishimoto M; Kosugi Y; Kobiyama K; Hara T; Toyoda M; Tanaka YL; Butlertanaka EP; Shimizu R; Ito H; Wang L; Oda Y; Orba Y; Sasaki M; Nagata K; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Kuramochi J; Seki M; Fujiki R; Kaneda A; Shimada T; Nakada TA; Sakao S; Suzuki T; Ueno T; Takaori-Kondo A; Ishii KJ; Schreiber G; ; Sawa H; Saito A; Irie T; Tanaka S; Matsuno K; Fukuhara T; Ikeda T; Sato K
    Cell; 2022 Jun; 185(12):2103-2115.e19. PubMed ID: 35568035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.
    Shuai H; Chan JF; Hu B; Chai Y; Yuen TT; Yin F; Huang X; Yoon C; Hu JC; Liu H; Shi J; Liu Y; Zhu T; Zhang J; Hou Y; Wang Y; Lu L; Cai JP; Zhang AJ; Zhou J; Yuan S; Brindley MA; Zhang BZ; Huang JD; To KK; Yuen KY; Chu H
    Nature; 2022 Mar; 603(7902):693-699. PubMed ID: 35062016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.
    Antia A; Alvarado DM; Zeng Q; Casorla-Perez LA; Davis DL; Sonnek NM; Ciorba MA; Ding S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
    Kimura I; Yamasoba D; Nasser H; Ito H; Zahradnik J; Wu J; Fujita S; Uriu K; Sasaki J; Tamura T; Suzuki R; Deguchi S; Plianchaisuk A; Yoshimatsu K; Kazuma Y; Mitoma S; Schreiber G; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Takaori-Kondo A; ; Ito J; Shirakawa K; Takayama K; Irie T; Hashiguchi T; Nakagawa S; Fukuhara T; Saito A; Ikeda T; Sato K
    J Virol; 2023 Oct; 97(10):e0101123. PubMed ID: 37796123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
    Carroll T; Fox D; van Doremalen N; Ball E; Morris MK; Sotomayor-Gonzalez A; Servellita V; Rustagi A; Yinda CK; Fritts L; Port JR; Ma ZM; Holbrook MG; Schulz J; Blish CA; Hanson C; Chiu CY; Munster V; Stanley S; Miller CJ
    PLoS Pathog; 2022 Feb; 18(2):e1009914. PubMed ID: 35143587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis.
    Zhang Y; Zhang T; Fang Y; Liu J; Ye Q; Ding L
    Signal Transduct Target Ther; 2022 Mar; 7(1):76. PubMed ID: 35264568
    [No Abstract]   [Full Text] [Related]  

  • 14. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48.
    Wang W; Jin Q; Liu R; Zeng W; Zhu P; Li T; Wang T; Xiang H; Zhang H; Chen Q; Gao Y; Lai Y; Yan F; Xia X; Li J; Wang X; Gao Y
    Front Immunol; 2024; 15():1427284. PubMed ID: 39411709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.
    Escalera A; Laporte M; Turner S; Karakus U; Gonzalez-Reiche AS; van de Guchte A; Farrugia K; Khalil Z; van Bakel H; Smith D; García-Sastre A; Aydillo T
    Emerg Microbes Infect; 2024 Dec; 13(1):2297553. PubMed ID: 38112266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo.
    Hui KPY; Ho JCW; Cheung MC; Ng KC; Ching RHH; Lai KL; Kam TT; Gu H; Sit KY; Hsin MKY; Au TWK; Poon LLM; Peiris M; Nicholls JM; Chan MCW
    Nature; 2022 Mar; 603(7902):715-720. PubMed ID: 35104836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
    Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
    Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.